GAGE12J
gene geneOn this page
Also known as OTTHUMG00000024137
Summary
GAGE12J (G antigen 12J, HGNC:17778) is a protein-coding gene on chromosome Xp11.23, encoding G antigen 12J (A6NER3).
At a glance
- Clinical variants (ClinVar): 10 total
- MANE Select transcript:
NM_001098406
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:17778 |
| Approved symbol | GAGE12J |
| Name | G antigen 12J |
| Location | Xp11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | OTTHUMG00000024137 |
| Ensembl gene | ENSG00000224659 |
| Ensembl biotype | protein_coding |
| OMIM | 300733 |
| Entrez | 729396 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000442437
RefSeq mRNA: 1 — MANE Select: NM_001098406
NM_001098406
CCDS: CCDS43939
Canonical transcript exons
ENST00000442437 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001628554 | 49322037 | 49322144 |
| ENSE00001781026 | 49326690 | 49326815 |
| ENSE00001800316 | 49323743 | 49323863 |
| ENSE00001948974 | 49329271 | 49329384 |
| ENSE00002450766 | 49323186 | 49323277 |
Expression profiles
Bgee: expression breadth broad, 82 present calls, max score 95.93.
Top tissues by expression
123 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 95.93 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 88.15 | gold quality |
| testis | UBERON:0000473 | 80.25 | gold quality |
| left testis | UBERON:0004533 | 79.67 | gold quality |
| right testis | UBERON:0004534 | 78.68 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| adenohypophysis | UBERON:0002196 | 36.92 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| right ovary | UBERON:0002118 | 32.07 | gold quality |
| pituitary gland | UBERON:0000007 | 31.75 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| urinary bladder | UBERON:0001255 | 31.06 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| blood | UBERON:0000178 | 29.74 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| nucleus accumbens | UBERON:0001882 | 28.72 | gold quality |
| metanephros cortex | UBERON:0010533 | 28.62 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| muscle of leg | UBERON:0001383 | 28.01 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| leukocyte | CL:0000738 | 27.30 | gold quality |
| gastrocnemius | UBERON:0001388 | 27.28 | gold quality |
| monocyte | CL:0000576 | 27.27 | gold quality |
Single-cell (SCXA)
Detected in 6 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-124263 | yes | 4398.86 |
| E-CURD-11 | yes | 359.88 |
| E-MTAB-6308 | yes | 342.65 |
| E-GEOD-134144 | yes | 26.62 |
| E-CURD-53 | no | 1632.58 |
| E-ANND-3 | no | 0.65 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Paralogs (22): PAGE1 (ENSG00000068985), PAGE4 (ENSG00000101951), XAGE2 (ENSG00000155622), PAGE5 (ENSG00000158639), XAGE3 (ENSG00000171402), XAGE5 (ENSG00000171405), GAGE2A (ENSG00000189064), PAGE3 (ENSG00000204279), XAGE1A (ENSG00000204379), XAGE1B (ENSG00000204382), GAGE1 (ENSG00000205777), GAGE12G (ENSG00000215269), GAGE10 (ENSG00000215274), GAGE12E (ENSG00000216649), GAGE12H (ENSG00000224902), GAGE12D (ENSG00000227488), PAGE2 (ENSG00000234068), GAGE12F (ENSG00000236362), GAGE12C (ENSG00000237671), PAGE2B (ENSG00000238269), GAGE13 (ENSG00000274274), GAGE2E (ENSG00000275113)
Protein
Protein identifiers
G antigen 12J — A6NER3 (reviewed: A6NER3)
All UniProt accessions (1): A6NER3
UniProt curated annotations — full annotation on UniProt →
Miscellaneous. This gene belongs to a multigene family expressed in a large variety of tumors whereas in normal tissues, expression is restricted to germ cells. These genes organized in clustered repeats, have a high degree of predicted sequence identity, but differ by scattered single nucleotide substitution. Their sequences contain either the antigenic peptide YYWPRPRRY or YRPRPRRY which is recognized by cytotoxic T-cells.
Similarity. Belongs to the GAGE family.
RefSeq proteins (1): NP_001091876* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR008625 | GAGE_fam | Family |
| IPR031320 | GAGE | Domain |
Pfam: PF05831
UniProt features (10 total): sequence variant 5, compositionally biased region 3, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NER3-F1 | 64.15 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 1 (showing top):
chrXp11
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
1185 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GAGE12J | PHGR1 | C9JFL3 | 473 |
| GAGE12J | PNLIPRP3 | Q17RR3 | 419 |
| GAGE12J | MUCL3 | Q3MIW9 | 394 |
| GAGE12J | CT47A11 | Q5JQC4 | 374 |
| GAGE12J | MAGEE1 | Q9HCI5 | 373 |
| GAGE12J | CYYR1 | Q96J86 | 372 |
| GAGE12J | ASTE1 | Q2TB18 | 371 |
| GAGE12J | TMSB4Y | O14604 | 370 |
| GAGE12J | VWA2 | Q5GFL6 | 370 |
| GAGE12J | MGAT4C | Q9UBM8 | 370 |
| GAGE12J | SCAND1 | P57086 | 351 |
| GAGE12J | MUC22 | E2RYF6 | 336 |
| GAGE12J | SPRR2E | P22531 | 324 |
| GAGE12J | HNRNPCL1 | O60812 | 323 |
| GAGE12J | ZNF208 | O43345 | 315 |
IntAct
114 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GAGE12J | MAST2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GAGE12J | DLG3 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GAGE12J | PDZD2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GAGE12J | WHRN | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GAGE12J | PTPN3 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| APBA3 | GAGE12J | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| PDZD7 | GAGE12J | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GAGE12J | NHERF4 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GAGE12J | MPP2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GAGE12J | DLG4 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GAGE12J | TAX1BP3 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GAGE12J | MAGI3 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GAGE12J | PDZK1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GAGE12J | LDB3 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GAGE12J | PALS2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GAGE12J | SNTG1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GAGE12J | SNX27 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GAGE12J | PICK1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GAGE12J | FRMPD2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GRID2IP | GAGE12J | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GAGE12J | ARHGAP21 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GAGE12J | SHANK1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GAGE12J | TJP1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GAGE12J | PTPN13 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| WHRN | GAGE12J | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GAGE12J | PATJ | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GAGE12J | GRIP1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GAGE12J | LIN7C | psi-mi:“MI:0407”(direct interaction) | 0.440 |
ESM2 similar proteins: A0A0U1RQG5, A1L429, A6NDE8, A6NER3, A6NGK3, E1AZ71, O08664, O60829, O75459, O76087, P0C2W7, P0CL80, P0CL81, P0CL82, P0DSO3, P0DTW1, P52651, P62521, P86478, P86479, P86480, P86481, P86496, Q13066, Q13069, Q13070, Q17QW4, Q28181, Q2T9P9, Q32PA2, Q4V321, Q4V326, Q5JQC4, Q5U2Y8, Q62100, Q63803, Q64256, Q6NT46, Q6X7S9, Q7Z2X7
Diamond homologs: A1L429, A6NDE8, A6NER3, A6NGK3, O75459, O76087, P0CL80, P0CL81, P0CL82, P0DSO3, P0DTW1, Q13066, Q13069, Q13070, Q4V321, Q4V326, Q6NT46, Q8WTP9, Q96GT9, Q9UEU5, Q8WWM1, Q5JUK9, Q5JRK9, Q7Z2X7, Q9HD64
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 74 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Ras activation upon Ca2+ influx through NMDA receptor | 5 | 58.3× | 8e-07 |
| Unblocking of NMDA receptors, glutamate binding and activation | 5 | 55.5× | 8e-07 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | 5 | 55.5× | 8e-07 |
| Long-term potentiation | 5 | 48.5× | 1e-06 |
| Assembly and cell surface presentation of NMDA receptors | 9 | 46.6× | 2e-11 |
| Neurexins and neuroligins | 10 | 40.2× | 7e-12 |
| Protein-protein interactions at synapses | 6 | 32.5× | 8e-07 |
| Neuronal System | 6 | 5.4× | 8e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| establishment or maintenance of epithelial cell apical/basal polarity | 11 | 88.8× | 6e-17 |
| protein localization to synapse | 6 | 63.8× | 4e-08 |
| receptor clustering | 7 | 60.7× | 4e-09 |
| regulation of postsynaptic membrane neurotransmitter receptor levels | 7 | 48.2× | 2e-08 |
| cell-cell adhesion | 10 | 14.1× | 2e-07 |
| protein-containing complex assembly | 8 | 12.7× | 1e-05 |
| chemical synaptic transmission | 7 | 7.5× | 1e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
10 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 9 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
550 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:49323184:A:AG | acceptor_gain | 1.0000 |
| X:49323185:G:GG | acceptor_gain | 1.0000 |
| X:49323185:GT:G | acceptor_gain | 1.0000 |
| X:49323716:A:AG | acceptor_gain | 1.0000 |
| X:49323716:ATTT:A | acceptor_gain | 1.0000 |
| X:49323717:T:G | acceptor_gain | 1.0000 |
| X:49323719:T:TA | acceptor_gain | 1.0000 |
| X:49323722:A:AG | acceptor_gain | 1.0000 |
| X:49323723:C:G | acceptor_gain | 1.0000 |
| X:49323724:A:AG | acceptor_gain | 1.0000 |
| X:49323725:C:G | acceptor_gain | 1.0000 |
| X:49323728:A:AG | acceptor_gain | 1.0000 |
| X:49323728:ACAC:A | acceptor_gain | 1.0000 |
| X:49323729:C:G | acceptor_gain | 1.0000 |
| X:49323730:A:AG | acceptor_gain | 1.0000 |
| X:49323730:AC:A | acceptor_gain | 1.0000 |
| X:49323731:C:CA | acceptor_gain | 1.0000 |
| X:49323731:C:G | acceptor_gain | 1.0000 |
| X:49323735:T:G | acceptor_gain | 1.0000 |
| X:49323741:A:AG | acceptor_gain | 1.0000 |
| X:49323742:G:GC | acceptor_gain | 1.0000 |
| X:49323830:G:GT | donor_gain | 1.0000 |
| X:49323845:G:GT | donor_gain | 1.0000 |
| X:49323876:G:T | donor_gain | 1.0000 |
| X:49326686:TAA:T | acceptor_loss | 1.0000 |
| X:49326687:A:AG | acceptor_gain | 1.0000 |
| X:49326687:AAG:A | acceptor_gain | 1.0000 |
| X:49326687:AAGG:A | acceptor_gain | 1.0000 |
| X:49326688:A:AG | acceptor_gain | 1.0000 |
| X:49326688:A:G | acceptor_gain | 1.0000 |
AlphaMissense
763 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:49323752:T:C | F32L | 0.828 |
| X:49323754:C:A | F32L | 0.828 |
| X:49323754:C:G | F32L | 0.828 |
| X:49323202:G:C | W3C | 0.622 |
| X:49323202:G:T | W3C | 0.622 |
dbSNP variants (sampled 300 via entrez): RS10126890 (X:49324883 G>A), RS10126926 (X:49324861 C>T), RS11091255 (X:49326937 C>G), RS11091256 (X:49327181 T>C,G), RS11091257 (X:49327464 C>T), RS111788301 (X:49320961 T>A), RS1137130 (X:49326707 G>C), RS1156297191 (X:49327342 T>C), RS1156353863 (X:49326692 C>T), RS1156448575 (X:49329395 G>A,C), RS1156661608 (X:49324023 C>G,T), RS1156875698 (X:49325443 A>G), RS1157549804 (X:49322349 G>A,T), RS1157875752 (X:49320483 T>A,C), RS1157921238 (X:49323543 C>T)
Disease associations
OMIM: gene MIM:300733 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases methylation | 1 |
| Cadmium | decreases expression | 1 |
| Lipopolysaccharides | affects expression, affects response to substance | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B1SL | Abcam HeLa GAGE12J KO | Cancer cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.